Connor, Clark & Lunn Investment Management Ltd.
Position in DHR — Danaher Corp /De/
CIK 1596800
VANCOUVER, A1
Position in DHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,716,624
-$2,822,545 QoQ
Shares Held
114,010
-11.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#330
of 2,105 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $189,818,037 across 16 Diagnostics & Research names. DHR ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
110,353 | $58,441,845 | |
| 2 | GH |
Guardant Health, Inc.
|
215,395 | $32,315,711 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
114,010 | $21,716,624 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
36,269 | $18,183,825 | |
| 5 | NEO |
Neogenomics Inc
|
802,597 | $11,709,889 | |
| 6 | RVTY |
Revvity, Inc.
|
87,145 | $9,695,752 | |
| 7 | MYGN |
Myriad Genetics Inc
|
1,407,860 | $8,038,880 | |
| 8 | CSTL |
Castle Biosciences Inc
|
331,727 | $7,911,688 |
All Filings in DHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,716,624 | 114,010 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,539,169 | 129,426 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,716,512 | 29,340 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $282,917 | 1,427 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,616,247 | 48,680 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $25,998,510 | 126,822 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,845,789 | 34,179 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $26,653,221 | 95,868 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $33,614,819 | 134,540 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $49,374,388 | 197,719 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,213,478 | 22,536 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $38,315,047 | 159,646 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $92,728,533 | 367,912 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $33,747,354 | 127,147 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $202,499 | 784 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $18,223,124 | 62,125 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $19,916,618 | 60,535 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $14,909,643 | 48,974 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $54,593,816 | 203,435 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $57,036,620 | 253,406 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $63,389,196 | 285,357 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $30,187,329 | 140,191 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,318,509 | 69,663 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||